Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Autosomal recessive pseudohypoaldosteronism type IB1 (PHA1B) is caused by biallelic loss-of-function variants in the epithelial sodium channel α-subunit gene SCNN1A. A 17-day-old Saudi female infant presenting with persistent hyperkalemia, hyponatremia, and metabolic acidosis was found to harbor a novel homozygous nonsense variant c.1522C>T (p.Arg508Ter) in SCNN1A, consistent with PHA1B diagnosis (PMID:39295704).
Genetic evidence for SCNN1A in PHA1B includes 17 affected individuals across five unrelated pedigrees, all showing autosomal recessive inheritance. Two siblings in one consanguineous family carried a homozygous missense variant c.398G>A (p.Cys133Tyr) with clinical salt wasting (PMID:12376807); a preterm neonate was homozygous for c.727T>C (p.Ser243Pro) and displayed transient salt loss (PMID:21653223); twelve patients from four families carried p.Phe226Cys, presenting mild and transient PHA1B (PMID:37134141); and a Somali neonate with c.1684T>C (p.Ser562Pro) showed systemic PHA1 (PMID:18547339).
Segregation analysis confirmed homozygous variants cosegregating with disease in two families, and all probands were homozygous or compound heterozygous for SCNN1A variants, supporting autosomal recessive transmission.
Functional assays in Xenopus laevis oocytes demonstrate drastic reductions (≥80%) in ENaC current for p.Cys133Tyr, p.Ser243Pro, p.Phe226Cys, and truncating p.Arg508Ter variants, and Western blot studies show reduced ENaC protein expression for p.Phe226Cys, indicating a loss-of-function mechanism concordant with human salt-wasting phenotypes.
No conflicting evidence has been reported for SCNN1A involvement in PHA1B. The collective genetic and functional data fulfill ClinGen criteria for a Strong gene–disease association between SCNN1A and PHA1B.
Key Take-home: Biallelic LOF variants in SCNN1A cause autosomal recessive PHA1B; genetic testing for SCNN1A should be integrated into diagnostic panels for neonatal salt-wasting syndromes to guide timely management.
Gene–Disease AssociationStrongSeventeen affected individuals across five unrelated families, autosomal recessive inheritance, concordant functional assays Genetic EvidenceStrongNine homozygous or biallelic pathogenic variants identified in eight unrelated probands; segregation in two families Functional EvidenceModerateXenopus oocyte assays show ≥80% reduction of ENaC activity and reduced protein expression for multiple SCNN1A variants |